Kathy Nicholls - Concepedia

Author

Kathy Nicholls

Also Known As

14 The Victorian, C Morgan, Dalziel, K., Jennette, Charles, Jenny Latte, Joanna Ghali, Josefina R. Cernadas, K M Nicholls, K NICHOLLS, K Nicholls

263

Publications

8.1K

Citations

H-Index

101

Concepts

All Affiliations

The Royal Melbourne Hospital The University of Melbourne University College London Dalhousie University Amicus Therapeutics (United States)

About

Kathy Nicholls is an author at The Royal Melbourne Hospital specializing in medicine, chronic kidney disease, and nephrology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.5K
2	Public Health	4	4	223
3	Health Sciences	3	3	152
4	Comparative Literature	3	3	78
5	Cell Biology	2	2	67

Kathy Nicholls

Publications

4.7K

Citations

H-Index

Page 1

	Year	Citations
Fabry disease: Baseline medical characteristics of a cohort of 1765 males and females in the Fabry Registry Christine M. Eng, Janice M. Fletcher, William R. Wilcox, Journal of Inherited Metabolic Disease	2007	381
Efficacy and Safety of Abatacept in Lupus Nephritis: A Twelve‐Month, Randomized, Double‐Blind Study Richard Furie, Kathy Nicholls, Tien‐Tsai Cheng, Arthritis & Rheumatology	2013	329
Cardiovascular Morbidity and Mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in Chronic Renal Failure Sophia Zoungas, Barry P. McGrath, Pauline Branley, Journal of the American College of Cardiology UrologyRenal DiseaseChronic Renal FailureCardiovascular DiseaseRenal Function	2006	238
Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst, Kidney International	2016	175
Cardiovascular Events in Patients With Fabry Disease Manesh R. Patel, Franco Cecchi, Marta Cizmarik, Journal of the American College of Cardiology Vascular DiseaseHeart FailureCardiovascular DiseaseCardiologyVascular Biology	2011	165
Agalsidase Alfa and Kidney Dysfunction in Fabry Disease Michael L. West, Kathy Nicholls, Atul Mehta, Journal of the American Society of Nephrology Glomerular DiseasePathologyGlomerulonephritisFabry DiseaseRenal Function	2009	160
HLA-DQA1 and PLCG2 Are Candidate Risk Loci for Childhood-Onset Steroid-Sensitive Nephrotic Syndrome Rasheed Gbadegesin, Adebowale Adeyemo, Nicholas J.A. Webb, Journal of the American Society of Nephrology	2014	145
Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: A 1‐year Phase 1/2 clinical trial Raphael Schiffmann, Özlem Göker-Alpan, Myrl Holida, Journal of Inherited Metabolic Disease	2019	133
Elevated plasma norepinephrine concentrations in decompensated cirrhosis. Association with increased secretion rates, normal clearance rates, and suppressibility by central blood volume expansion. Kathy Nicholls, Michael D. Shapiro, Vicki J. Van Putten, Circulation Research Renal FunctionNormal Clearance RatesPlasma Norepinephrine ConcentrationsElectrolyte DisturbanceClinical Chemistry	1985	123
Renal dialysis abatement: lessons from a social study Michael Ashby, Corinne op’t Hoog, Allan Kellehear, Palliative Medicine	2005	122

Page 1